Status:
COMPLETED
In-Office Tympanostomy Tube Placement in Children (OTTER)
Lead Sponsor:
Tusker Medical
Conditions:
OME - Otitis Media With Effusion
AOM - Acute Otitis Media
Eligibility:
All Genders
6-12 years
Phase:
PHASE3
Brief Summary
A prospective, single-arm, multicenter study to evaluate effectiveness and safety of Tymbion iontophoresis and tympanostomy tube placement using the Tula Iontophoresis and Tube Delivery Systems for ch...
Detailed Description
The objective of this study is to evaluate effectiveness and safety of tympanostomy tube (TT) placement in children following local anesthesia in a physician's clinic setting (henceforth referred to a...
Eligibility Criteria
Inclusion
- Males or females at least 6 months old through 12 years old at time of consent
- Indication for tympanostomy tube insertion per Clinical Practice Guideline
- Behavioral capacity and cooperative temperament to undergo an awake procedure, based on physician judgment (not applicable to OR Lead-In subjects)
- Subject's parent/guardian and subject are able and willing to comply with the protocol and attend all study visits
- Subject's parent/guardian and subject are able and willing to provide informed consent or assent as age appropriate
Exclusion
- Significantly atrophic, retracted, bimeric, monomeric or atelectatic tympanic membrane
- Perforated tympanic membrane
- Otitis externa
- Active or recent conditions of the tympanic membrane (eg, prior myringotomy with incomplete wound healing or re-epithelization)
- Hemotympanum
- Damaged/denuded skin in the auditory canal
- Cerumen impaction resulting in a significant amount of cleaning required to visualize the tympanic membrane potentially causing abrasion or irritation to the external ear canal
- Anatomy that precludes sufficient visualization of and access to the tympanic membrane
- Anatomy that necessitates tympanostomy tube placement in the posterior half of the tympanic membrane
- History of sensitivity or allergic reaction to lidocaine HCl, tetracaine, epinephrine, or any hypersensitivity to local anesthetics of the amide type, or any component of the anesthetic drug formulation (not applicable to OR Lead-In subjects)
- Familial history of insensitivity to lidocaine or other local anesthetics of the amide type (eg, history of inadequate anesthesia with dental numbing agents). (not applicable to OR Lead-In subjects)
- Electrically sensitive medical support systems (eg, pacemakers, defibrillators, cochlear implants)
- Other conditions that would preclude performing the study procedure including iontophoresis system ear plug incompatibility.
- Health conditions that, in the opinion of the investigator, would present undue risk to the subject, based on device/anesthetic drug product label warnings and precautions.
- Subject is 4 years or older and not able to complete all baseline assessments. Subject is younger than 4 years and not able to complete all baseline assessments, not including audiometry.
Key Trial Info
Start Date :
October 31 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 25 2021
Estimated Enrollment :
370 Patients enrolled
Trial Details
Trial ID
NCT03323736
Start Date
October 31 2017
End Date
March 25 2021
Last Update
May 26 2022
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
California Head and Neck Specialists
Carlsbad, California, United States, 92008
2
Sacramento ENT
Roseville, California, United States, 95661
3
Camino Ear Nose & Throat Clinic
San Jose, California, United States, 95138
4
Connecticut Children's Medical Center
Hartford, Connecticut, United States, 06106